Association of De Novo RNF213 Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To test the hypothesis that de novo genetic variants are responsible for moyamoya disease (MMD) in children with unaffected relatives, we performed exome sequencing of 28 affected children and their unaffected parents.
Methods Exome sequencing was performed on 28 trios of affected patients with MMD and unaffected parents.
Results We identified 3 novel rare de novo RNF213 variants, 1 in the RING domain and 2 in a highly conserved region distal to the RING domain (4,114–4,120). These de novo cases of MMD present at a young age with aggressive MMD and uniquely have additional occlusive vascular lesions, including renal artery stenosis. Two previously reported cases had de novo variants in the same limited region and presented young with aggressive MMD, and 1 case had narrowing of the inferior abdominal aorta.
Conclusions These results indicate a novel syndrome associated with RNF213 rare variants defined by de novo mutations disrupting highly conserved amino acids in the RING domain and a discrete region distal to the RING domain delimited by amino acids 4,114 to 4,120 leading to onset of severe MMD before 3 years of age and occlusion of other arteries, including the abdominal aorta, renal, iliac, and femoral arteries.
Glossary
- CADD=
- Combined Annotation Dependent Depletion;
- EDAS=
- encephaloduroarteriosynangiosis;
- MELAS=
- mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes;
- MMD=
- moyamoya disease;
- PAH=
- pulmonary artery hypertension;
- PHACE=
- posterior fossa brain malformations, hemangioma, arterial lesions, cardiac abnormalities, and eye abnormalities;
- SMDS=
- smooth muscle dysfunction syndrome
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received July 22, 2020.
- Accepted in final form December 23, 2020.
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Clinical/Scientific Notes
Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11Annette Keylock, Ying Hong, Dawn Saunders et al.Neurology, December 20, 2017 -
Articles
Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRIR. H. Swartz, S. S. Bhuta, R. I. Farb et al.Neurology, February 16, 2009 -
Clinical/Scientific Notes
GIANT CELL ARTERITIS OF THE BASAL CEREBRAL ARTERIES: CORRELATION OF MRI, DSA, AND HISTOPATHOLOGYT. Pfefferkorn, U. Schüller, C. Cyran et al.Neurology, May 17, 2010 -
Case
Recurrent stroke in a patient with vitamin B12 deficiency and MTHFR mutationGeorge Zacharia, Dana Shani, Rafael A. Ortiz et al.Neurology: Clinical Practice, April 01, 2016